House lawmakers have pushed back committee consideration of the National Defense Authorization Act, which advocates hoped to see advance with marijuana reform provisions included, amid disputes over multiple issues, Kyle Jaeger of Marijuana Moment reported. At the same time, offices of several Republican senators met with the Department of Justice to talk about their concerns with pending cannabis banking reforms. The NDAA is being closely watched to see if it will be used as a vehicle for marijuana banking and other reform legislation, but Chairman Jim McGovern said the package is not ready yet. Publicly traded companies in the space include Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), Goodness Growth (GDNSF), Green Thumb Industries (GTBIF), India Globalization Capital (IGC), Tilray (TLRY), Trulieve Cannabis (TCNNF) and Zynerba (ZYNE). Reference Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ACB:
- Aurora Cannabis repurchases $76.1M of convertible senior notes
- White House announces signing of medical marijuana research expansion act
- Here’s What You Missed in Cannabis This Week
- Aurora Cannabis sees adjusted EBITDA profitability by December 31
- Aurora Cannabis reports Q1 revenue C$49.3M, consensus C$52.5M